FDA Inspection 1301062 — LINGHAM & SONS (MALAYSIA) SDN. BHD.
The FDA completed an inspection of LINGHAM & SONS (MALAYSIA) SDN. BHD. on Jan 20, 2026 in Semenyih. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 8 citations were issued during this inspection. Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- Jan 20, 2026
- Fiscal Year
- 2026
- Product Type
- Food/Cosmetics
- Project Area
- Food Composition, Standards, Labeling and Econ
- Location
- Semenyih (Malaysia)
Citations
| ID | CFR | Description |
|---|---|---|
| 22702 | 21 CFR 117.135(a)(1) | Process preventive controls - Identify (Written) |
| 22717 | 21 CFR 117.130(a)(1) | Hazard analysis - Identification of hazard |
| 22718 | 21 CFR 117.135(c)(1) | Process preventive controls - Appropriate (Adequate) |
| 3062 | 21 CFR 114.10 | Personnel |
| 3075 | 21 CFR 114.80(a)(4) | Container testing |
| 3080 | 21 CFR 114.83 | Scheduled process establishment |
| 3091 | 21 CFR 114.100(e) | Retention |
| 4470 | 21 CFR 108.25(c)(2) | Process filing |